MoonLake Immunotherapeutics
- Last sale
- Nov 12, 2026 · -4.70%
- Market cap
- $1.10B
- 85.11M shares
- Filings
- 331
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+85.4% FY25 yoy
- $1.10B
- —
- —
- 2.9×
- -17.90%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $202,862,000 | reported | |
| FY 2024 | 2024-12-31 | $112,771,000 | reported | |
| FY 2023 | 2023-12-31 | $31,802,000 | reported | |
| FY 2022 | 2022-12-31 | $42,048,954 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $50.00 | $50.00 | — | — | — | — |
| FY2023 | — | $0.00 | $0.00 | — | — | — | — |
| FY2022 | — | $0.00 | $0.00 | — | — | — | — |
Segments
Geography
LineFY2025ShareChange
Portugal$1.02M47%−19.1%
United Kingdom$804.00K38%−54.8%
Switzerland$322.00K15%−47.2%
United States$0.00——
Total$2.14M
Pharmaceutical preparations
MoonLake Immunotherapeutics is the 141st largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
AMPHAmphastar Pharmaceuticals, Inc.$719.9M1.7%13.6%$1.2BGHRSGH Research PLC———$1.1BJBIOJade Biosciences, Inc.———$1.1B
MLTXMoonLake Immunotherapeutics (this company)———$1.1B
SPTXSeaport Therapeutics, Inc.———$1.1BVSTMVerastem, Inc.$30.9M209.1%677.6%$1.1BHROWHarrow, Inc.$272.3M36.4%1.9%$1.1BSVRASavara Inc———$1.0BJANXJanux Therapeutics, Inc.$10.0M5.6%1,136.3%$1.0BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
MoonLake Immunotherapeutics · CIK 1821586 · Engraved from SEC EDGAR